Detalhe da pesquisa
1.
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.
Cell
; 184(9): 2316-2331.e15, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773105
2.
Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope.
Cell
; 184(17): 4414-4429.e19, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416146
3.
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress.
Cell
; 184(17): 4430-4446.e22, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416147
4.
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.
Nat Immunol
; 22(12): 1503-1514, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716452
5.
Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interface.
Immunity
; 57(6): 1413-1427.e9, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38823390
6.
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection.
Cell
; 174(4): 938-952.e13, 2018 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096313
7.
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability.
Cell
; 169(5): 891-904.e15, 2017 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28525756
8.
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection.
Cell
; 164(3): 392-405, 2016 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26806128
9.
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization.
Immunity
; 52(2): 388-403.e12, 2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32023489
10.
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein.
Immunity
; 49(2): 363-374.e10, 2018 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30029854
11.
Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses.
PLoS Pathog
; 19(10): e1011722, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37812640
12.
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
J Virol
; 97(7): e0159622, 2023 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37395646
13.
Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function.
J Virol
; 96(11): e0007122, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575481
14.
A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
J Virol
; 95(9)2021 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33597214
15.
Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice.
Nature
; 540(7633): 443-447, 2016 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27819683
16.
Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope.
Proc Natl Acad Sci U S A
; 116(5): 1591-1596, 2019 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30642974
17.
Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles.
Proc Natl Acad Sci U S A
; 115(22): E4990-E4999, 2018 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29769329
18.
Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2.
J Virol
; 93(14)2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31068427
19.
Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection.
J Virol
; 93(8)2019 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30728263
20.
Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis.
PLoS Pathog
; 13(12): e1006735, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29253863